期刊文献+

抗肿瘤适体药物的研究进展 被引量:6

Development of anticancer aptamer drugs
下载PDF
导出
摘要 适体,也称为化学抗体,是近年来开发的颇具潜力的一类新型药物。适体由较短的DNA或RNA寡聚核酸组成,在体内形成专一和稳定的三维结构,可以与特定的靶蛋白结合。已批准上市的第1个适体药物为抗血管内皮生长因子的RNA分子Macugen,在临床上玻璃体内注射用于治疗年龄相关性黄斑变性。细胞和动物模型研究证明一些适体具有很好的抗癌作用,有几个适体药物已进入临床研究阶段。此文对近年来抗肿瘤适体药物的进展做一综述。
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2009年第6期415-418,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 国家高技术研究发展计划"863计划"资助项目(2008AA02Z135) 国家科技重大专项课题(2009ZX09103-643) 福建省科技计划重点项目(2009I0017)
关键词 适体 肿瘤 药物
  • 相关文献

参考文献32

  • 1Ng E W, Shima D T, Calias P, et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease [ J ]. Nat Rev Drug Discov, 2006,5 (2) : 123-132.
  • 2吴海歌,姚子昂,白雪芳,杜昱光,林炳承.抑制肿瘤血管生成治疗策略研究进展[J].中国生化药物杂志,2007,28(2):130-132. 被引量:6
  • 3苏伟明,于立坚,马润娣,廖铭能,黄来珍,于廷曦.从赤组织中分离到的福安肽的抗肿瘤活性的初步研究[J].中国生化药物杂志,2008,29(1):9-11. 被引量:14
  • 4Cel.ec P,Yonemitsu Y. Vascular endothelial growth factor-basic science and its c hnical implications [ J ]. Pathophysiology, 2004,11 ( 2 ) : 69 -75.
  • 5Lee J H,Canny M D, De Erkenez,et al. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165[J]. Proc Natl Acad Sci USA,2005,102(52):18902-18907.
  • 6Huang J, Moore J, Softer S, et al. Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors [ J ]. J Pediatr Surg,2001,36(2) :357-361.
  • 7Cao Y, Zhong W, Sun Y. Improvement of antiangiogenic caneer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance [J]. Semin Cancer Biol,2009,in press.
  • 8Kim E S, Serur A, Huang J, et al. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma[ J]. Proc Natl Acad Sci USA,2002,99(17) : 11399-11404.
  • 9Stoeltzing O, Ahmad S A, Liu W, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors [ J]. Cancer Res, 2003,63 (12) : 3370-3377.
  • 10White R R, Shah S, Rusconi C P, et al. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 [J]. Proc Natl Acad Sci USA,2003,100(9) :5028-5033.

二级参考文献55

  • 1Folkman J.Tumor angiogenesis:therapeutic implications[J].New England J Med,1971,285(21):1182-1186.
  • 2Gordon M S,Margolin K,Talpaz M,et al.Phase Ⅰ safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer[J].J Clin Oncol,2001,19(3):843-850.
  • 3Ignoffo R J.Overview of bevacizumab:A new cancer therapeutic strategy targeting vascular endothelial growth factor[J].Am J Health Syst Pharm,2004,61 (21):21-26.
  • 4Wang E S,Teruya-Feldstein J,Wu Yan,et al.Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo[J].Blood,2004,104(9):2893-2902.
  • 5Gomer G M,Ciulla T A.Pharmacotherapy for diabetic retinopathy[J].Curr Opin Ophthalmol,2004,15 (6):508-518.
  • 6Lin P,Sankar S,Shan S,et al.Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor[J].Cell Growth Differ,1998,9(1):49-58.
  • 7Holash J,Davis S,Papadopoulos N,et al.VEGF-Trap:A VEGF blocker with potent antitumor effects[J].Proc Natl Acad Sci USA,2002,99(17):11393-11398.
  • 8Bergers G,Song S,Meyer-Morse N,et al.Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors[J].J Clin Invest,2003,111 (9):1287-1295.
  • 9Shaheen R M,Tseng W W,Davis D W,et al.Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms[J].Cancer Res,2001,61(4):1464-1468.
  • 10Schoenberger J,Grimm D,Kossmehl P,et al.Effects of PTK787/ZK222584,a tyrosine kinase inhibitor,on the growth of a poorly differentiated thyroid carcinoma:An animal study[J].Endocrinology,2004,145(3):1031-1038.

共引文献19

同被引文献92

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部